Final positive results of the pivotal phase III clinical study in immunocompetent patients with recurrent herpes labialis (LIP Study) treated with acyclovir Lauriad were announced.

Link:http://www.bioalliancepharma.com/eng/content/download/5352/59895/version/1/file/091210EN_Acyclovir.pdf
Source:BioAlliance